公司资料

Bruker 股价、新闻与催化剂

股票代码:
BRKR
交易所:
NASDAQ
行业:
Biopharma
所在地:
United States

股票表现

57.67 USD (-0.05%)

收盘价

最后更新: 2026年8月17日

8.72B USD

市值

股价为何变动

As of Aug 17, 2026, BRKR was little changed and closed at $57.67. No new same-company headline was identified in the current news window.

公司概览

Scientific Instrumentation

Bruker develops high-performance scientific instruments and analytical solutions used to study life and materials at molecular, cellular and microscopic scales.

Life-Science Research

Its systems support molecular and cell biology, proteomics, multiomics, spatial and single-cell biology, structural biology and preclinical imaging. These tools serve academic, government and biopharmaceutical research laboratories.

Clinical Diagnostics

Bruker provides specialty diagnostic technologies for clinical microbiology, molecular diagnostics and phenomics research, connecting its instrument base with healthcare applications.

Materials and Nanoanalysis

The company also supplies microscopy, spectroscopy and nanoanalysis systems for industrial, energy, clean-technology and advanced-materials research.

Semiconductor Metrology

Bruker's semiconductor tools perform next-generation metrology and process analysis, giving the company exposure to advanced chip manufacturing and infrastructure supporting artificial intelligence.

未来催化剂

    近期新闻

    1. 01
    2. 02
    3. 03
    4. 04
    5. 05

    相似股票

    商业成熟度、治疗领域或催化剂模式相近的同行公司。